Medicare Enrolled
Dr. Lee Blatstein, DO
Urology Physician · Lansdale, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Blatstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Blatstein?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Blatstein
Dr. Lee Blatstein is an urology physician in Lansdale, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Blatstein performed 3,387 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Blatstein received a total of $3,858 from 33 pharmaceutical and/or device companies across 174 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Blatstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 18% volume in PA
$3,858 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,387
Medicare services
Top 18% in PA for urology physician
Not available
Unique patients (not deduplicated)
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,007 | $2 | $10 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
580 | $8 | $60 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
561 | $62 | $190 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
522 | $95 | $275 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
165 | $196 | $700 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 88 | $137 | $755 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
85 | $131 | $350 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
69 | $65 | $130 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
50 | $139 | $500 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
50 | $69 | $275 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
40 | $105 | $245 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
38 | $87 | $291 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
22 | $98 | $190 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
18 | $49 | $275 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
17 | $25 | $130 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
16 | $464 | $2,890 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
16 | $20 | $180 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
16 | $27 | $115 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
15 | $148 | $350 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
12 | $68 | $175 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$3,858
Total received (2018-2024)
Avg $551/year across 7 years
Top 34% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
174
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,110
2023
$1,239
2022
$92
2021
$62
2020
$93
2019
$587
2018
$675
Payments by company (2024)
Sumitomo Pharma America, Inc.
$211
Janssen Biotech, Inc.
$192
180 Medical, Inc.
$169
Astellas Pharma US Inc
$147
ConvaTec Inc.
$84
Ferring Pharmaceuticals Inc.
$69
ABBVIE INC.
$49
Teleflex LLC
$44
Blue Earth Diagnostics Limited
$29
Endo USA, Inc.
$24
PFIZER INC.
$21
COLOPLAST CORP
$19
Novartis Pharmaceuticals Corporation
$18
IMMUNITYBIO, INC.
$17
Myriad Genetic Laboratories, Inc.
$17
Top 3 companies account for 51.5% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$688
Janssen Biotech, Inc.
$685
Sumitomo Pharma America, Inc.
$357
AbbVie, Inc.
$215
Bayer Healthcare Pharmaceuticals Inc.
$191
180 Medical, Inc.
$185
ConvaTec Inc.
$177
AbbVie Inc.
$166
Agiliti Surgical, Inc.
$102
Teleflex LLC
$99
Myriad Genetic Laboratories, Inc.
$99
PFIZER INC.
$96
Ferring Pharmaceuticals Inc.
$86
Amgen Inc.
$78
Blue Earth Diagnostics Limited
$75
Endo Pharmaceuticals Inc.
$71
ABBVIE INC.
$69
Boston Scientific Corporation
$52
TOLMAR Pharmaceuticals, Inc.
$52
C. R. BARD, INC. & SUBSIDIARIES
$44
Progenics Pharmaceuticals, Inc.
$34
NeoTract Inc.
$33
Bayer HealthCare Pharmaceuticals Inc.
$25
Endo USA, Inc.
$24
Alnylam Pharmaceuticals Inc.
$20
UroGen Pharma, Inc.
$20
COLOPLAST CORP
$19
Novartis Pharmaceuticals Corporation
$18
IMMUNITYBIO, INC.
$17
Coloplast Corp
$17
Avadel Specialty Pharmaceuticals, LLC
$16
Aytu BioScience, Inc
$15
DENTSPLY IH Inc.
$11
Top 3 companies account for 44.9% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ANKTIVA · AVEED · Androgel · Axumin · BOTOX · Coloplast TFL Drive · ELIGARD · ERLEADA · Erleada · GEMTESA · GENTLECATH · GREENLIGHT · JELMYTO · LITHOVUE · LUPRON DEPOT · LoFric · Lupron · Lupron Depot · MYRBETRIQ · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OXLUMO · PLUVICTO · POSLUMA · PROLARIS · PYLARIFY · Prolaris · Prolia · Rezum Generator · SPEEDICATH · TOVIAZ · UROLIFT · UroLift · Veozah · XIAFLEX · XTANDI · Xtandi · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
260
County median income
$111,521
Nearest hospital to ZIP centroid (approximate)
JEFFERSON LANSDALE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Blatstein is a clinical cardiology specialist, with above-average Medicare volume (top 18% in PA), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Blatstein experienced with automated urinalysis?
Based on Medicare claims data, Dr. Blatstein performed 1,007 automated urinalysis services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Blatstein receive payments from pharmaceutical companies?
Yes. Dr. Blatstein received a total of $3,858 from 33 companies across 174 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Blatstein's costs compare to other urology physicians in Lansdale?
Dr. Blatstein's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Blatstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Lansdale
Browse urology physicians in Lansdale ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology